-
公开(公告)号:US06335020B1
公开(公告)日:2002-01-01
申请号:US08464000
申请日:1995-06-05
申请人: Bruce Rogers , David G. Klapper , Thorunn Rafnar , Mei-chang Kuo
发明人: Bruce Rogers , David G. Klapper , Thorunn Rafnar , Mei-chang Kuo
IPC分类号: A61K3935
CPC分类号: G01N33/68 , A61K38/00 , A61K39/00 , C07K14/415 , C07K16/16 , C07K2317/34 , G01N2333/415
摘要: Antigen E or Amb a I of ragweed pollen has been shown to be a family or families of proteins. cDNAs encoding Amb a I, the major human allergen of ragweed and Amb a II, peptides derived from Amb a I or Amb a II, antibodies against the peptides; and methods of treating individuals for sensitivity to ragweed are disclosed.
摘要翻译: 豚草花粉的抗原E或Amb a I已被证明是家族或蛋白质家族。 编码Amba I的cDNA,豚草和Amb a II的主要人类过敏原,源自Amb a I或Amb a II的肽,针对肽的抗体; 并公开了治疗个体对豚草敏感性的方法。
-
2.
公开(公告)号:US06602509B1
公开(公告)日:2003-08-05
申请号:US09362731
申请日:1999-07-29
IPC分类号: A61K3935
CPC分类号: C07K14/43531 , A61K38/00 , A61K2039/51 , C07K14/31 , C07K14/38 , C07K14/4717 , C07K2319/00 , Y10S977/915
摘要: The present invention is related to a compound for the prevention and/or the treatment of allergy consisting of: at least one allergen antigenic determinant which is recognized by a B cell or an antibody secreted by a B cell of a non-atopic individual to said allergen, and at least one antigenic determinant of an antigen different from said allergen which triggers T cell activation.
摘要翻译: 本发明涉及一种用于预防和/或治疗过敏的化合物,其包含:至少一种被B细胞识别的至少一种变应原抗原决定簇或由所述非特异性个体的B细胞分泌的抗体 过敏原,以及不同于触发T细胞活化的所述变应原的抗原的至少一种抗原决定簇。
-
公开(公告)号:US06187311B1
公开(公告)日:2001-02-13
申请号:US08930264
申请日:1997-09-26
IPC分类号: A61K3935
CPC分类号: C07K14/43531 , A61K38/00
摘要: The invention provides a method for producing a modified major mite allergen, obtained by altering a major allergen of house dust mites by gene engineering, which involve the steps of culturing prokaryotic or eukaryotic host cells transformed with a replication vector containing a gene encoding modified major mite allergen expressed from a promoter and collecting the expressed modified major mite allergen from the culture. The present invention provides a modified major mite allergen produced by the method, DNA molecules encoding same, and a pharmaceutical composition containing the modified major mite allergen.
摘要翻译: 本发明提供了通过基因工程改变房尘螨的主要变应原而获得的改性的主要螨变应原的方法,其涉及培养用含有编码修饰的主要螨的基因的复制载体转化的原核或真核宿主细胞的步骤 由启动子表达的变应原并从培养物中收集表达的修饰的主要螨变应原。 本发明提供了通过该方法生产的修饰的主要螨变应原,编码它的DNA分子和含有改性的主要螨变应原的药物组合物。
-
公开(公告)号:US06451324B1
公开(公告)日:2002-09-17
申请号:US08434256
申请日:1995-05-03
申请人: Mohan Bir Singh , Robert Bruce Knox , Penelope Smith , Asil Avjioglu , Piyada Theerakulpisut , Terryn Hough
发明人: Mohan Bir Singh , Robert Bruce Knox , Penelope Smith , Asil Avjioglu , Piyada Theerakulpisut , Terryn Hough
IPC分类号: A61K3935
CPC分类号: C07K16/16 , C07K14/415 , C12N15/8289 , G01N33/569 , G01N33/56961 , G01N33/6893 , G01N2800/24
摘要: The present invention provides a nucleic acid sequences coding for the ryegrass pollen allergens Lol pIa and Lol pIb, purified Lol pIa and Lol pIb protein and fragments thereof, methods of producing recombinant Lol pIa and Lol pIb or at least one fragment thereof or derivative or homologue thereof, and methods of using the nucleic acid sequences, proteins and peptides of the invention.
摘要翻译: 本发明提供了编码黑麦草花粉过敏原Lol pIa和Lol pIb,纯化的Lol pIa和Lol pIb蛋白及其片段的核酸序列,产生重组Lol pIa和Lol pIb的方法或其至少一种片段或衍生物或同系物 以及使用本发明的核酸序列,蛋白质和肽的方法。
-
公开(公告)号:US06197313B1
公开(公告)日:2001-03-06
申请号:US08434418
申请日:1995-05-03
申请人: Mohan Bir Singh , Robert Bruce Knox , Penelope Smith , Asil Avjioglu , Piyada Theerakulpisut , Terryn Hough
发明人: Mohan Bir Singh , Robert Bruce Knox , Penelope Smith , Asil Avjioglu , Piyada Theerakulpisut , Terryn Hough
IPC分类号: A61K3935
CPC分类号: C07K16/16 , C07K14/415 , C12N15/8289 , G01N33/569 , G01N33/56961 , G01N33/6893 , G01N2800/24
摘要: The present invention provides a nucleic acid sequences coding for the ryegrass pollen allergens Lol pIa and Lol pIb, purified Lol pIa and Lol pIb protein and fragments thereof, methods of producing recombinant Lol pIa and Lol pIb or at least one fragment thereof or derivative or homologue thereof, and methods of using the nucleic acid sequences, proteins and peptides of the invention.
-
公开(公告)号:US06800290B2
公开(公告)日:2004-10-05
申请号:US09949889
申请日:2001-09-12
申请人: Monica Sturaro , Angelo Viotti , Paolo Falagiani , Giovanni Mistrello , Daniela Roncarolo , Stefania Zanotta
发明人: Monica Sturaro , Angelo Viotti , Paolo Falagiani , Giovanni Mistrello , Daniela Roncarolo , Stefania Zanotta
IPC分类号: A61K3935
CPC分类号: A61K31/198 , A61K9/0019 , A61K31/195 , A61K31/335 , A61K31/40 , A61K31/565 , A61K31/70 , A61K31/704 , A61K38/00 , A61K45/06 , A61K47/183 , C07K14/43531 , Y10S530/858 , Y10S530/868 , A61K2300/00
摘要: Variants of allergens of Dermatophagoides pteronyssinus species with reduced allergenic activity.
摘要翻译: Dermatophagoides pteronyssinus物种变应原的变异,具有降低的过敏活性。
-
公开(公告)号:US06572859B1
公开(公告)日:2003-06-03
申请号:US09696169
申请日:2000-10-26
申请人: Rudolf Valenta , Susanne Vrtala , Sabine Stummfoll , Hans Grönlund , Monika Grote , Luca Vangelista , Annalisa Pastore , Wolfgang R. Sperr , Peter Valent , Dietrich Kraft
发明人: Rudolf Valenta , Susanne Vrtala , Sabine Stummfoll , Hans Grönlund , Monika Grote , Luca Vangelista , Annalisa Pastore , Wolfgang R. Sperr , Peter Valent , Dietrich Kraft
IPC分类号: A61K3935
CPC分类号: C07K14/415 , A61K38/00 , A61K39/00 , A61K39/36 , Y10S424/805 , Y10S424/81 , Y10S530/806 , Y10S530/868
摘要: The invention relates to a hypoallergenic immunogenic molecule derived from the Phl p 6 allergen, wherein the Phl p6 molecule has an N-terminal and/or C-terminal deletion which makes the molecule at least substantially lack IgE binding capacity. The invention also relates to a hypoallergenic immunogenic combination of molecules derived from the Phl p 6 allergen, comprising (i) a Phl p 6 molecule having an N-terminal deletion which makes the molecule at least substantially lack IgE binding capacity, and (ii) a Phl p 6 molecule having a C-terminal deletion which makes the molecule at least substantially lack IgE binding capacity, which two molecules together encompass the complete sequence of Phl p 6. The invention further relates to the use of the hypoallergenic immunogenic molecule or molecule mixture in hyposensitization and diagnosis.
-
公开(公告)号:US06214358B1
公开(公告)日:2001-04-10
申请号:US08441507
申请日:1995-05-15
IPC分类号: A61K3935
CPC分类号: C07K14/415 , A61K38/00
摘要: The present invention provides nucleic acid sequences coding Cyn d I, or at least one fragment thereof or the functional equivalent of such nucleic acid sequences. The present invention also provides expression vectors comprising such nucleic acid sequences and host cells transformed therewith. The present invention further provides isolated Bermuda grass pollen protein allergen Cyn d I or fragments thereof. Isolated Bermuda grass pollen protein allergens or antigenic or allergenic fragments thereof are useful for diagnosing and treating sensitivity in an individual to Bermuda grass pollen allergens.
摘要翻译: 本发明提供了编码Cynd I或其至少一个片段或这些核酸序列的功能等同物的核酸序列。 本发明还提供了包含这种核酸序列的表达载体和用其转化的宿主细胞。 本发明还提供了分离的百慕大草花粉蛋白过敏原Cynd I或其片段。 分离的百慕大草花粉蛋白过敏原或其抗原或过敏性片段可用于诊断和治疗个体对百慕大草花粉过敏原的敏感性。
-
9.
公开(公告)号:US06423837B1
公开(公告)日:2002-07-23
申请号:US09295188
申请日:1999-04-20
申请人: Wayne Robert Thomas , Kaw-Yan Chua
发明人: Wayne Robert Thomas , Kaw-Yan Chua
IPC分类号: A61K3935
CPC分类号: C07K14/5403 , A61K38/00 , C07K14/43531
摘要: Isolated DNA encoding allergens of Dermatophagoides (house dust mites) particularly of the species Dermatophagoides farinae and Dermatophagoides pteronyssinus, which are protein allergens or peptides which include at least one epitope of the protein allergen. In particular, DNA encoding two major D. farinae allergens, Der f I and Der f II and DNA encoding a D. pteronyssinus allergen, Der p I. In addition, the proteins or peptides encoded by the isolated DNA, their use as diagnostic and therapeutic reagents and methods of diagnosing and treating sensitivity to house dust mite allergens.
摘要翻译: 编码Dermatophagoides(房尘螨)变应原的分离的DNA,特别是Dermatophagoides farinae和Dermatophagoides pteronyssinus,它们是蛋白质过敏原或包括蛋白质变应原的至少一个表位的肽。 特别地,编码两个主要的D. farinae过敏原的DNA,Der f I和Der f II以及编码D.pteronyssinus变应原的DNA,Der p I.另外,由分离的DNA编码的蛋白质或肽,它们用作诊断和 诊断和治疗房屋尘螨过敏原敏感性的治疗试剂和方法。
-
公开(公告)号:US06350590B1
公开(公告)日:2002-02-26
申请号:US09530277
申请日:2000-06-23
IPC分类号: A61K3935
CPC分类号: C07K14/43527 , A61K39/35 , A61K39/36 , C07K1/12 , C07K1/34
摘要: The present invention relates to a process for the controlled enzymatic cleavage of purified and depigmented active allergenic proteins from indoor and outdoor source materials, which process produces fragments of allergens that retain the the natural T-lymphocyte stimulating epitopes, but are depleted of IgE-binding B-cell epitopes and complement-activating agents. The invention also relates to the new pharmaceutical products. These allergen fragments do not exhibit the disadvantages of conventional allergenic extracts for immunotherapy and can be safely used to induce a state of specific T-cell anergy and immunological tolerance in allergic human beings.
摘要翻译: 本发明涉及从室内和室外来源材料中对被纯化和脱色的活性变应原蛋白进行受控酶切割的方法,该方法产生保留天然T淋巴细胞刺激表位但是耗尽IgE结合的变应原片段 B细胞表位和补体活化剂。 本发明还涉及新的药物产品。 这些变应原片段不表现出常规的过敏原提取物用于免疫治疗的缺点,并且可以安全地用于诱导过敏人体中特异性T细胞无反应性和免疫耐受性的状态。
-
-
-
-
-
-
-
-
-